Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Supply of Doxycycline Monohydrate for Oral Suspension

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the supply of Doxycycline Monohydrate for Oral Suspension to prime contractors supporting Defense Logistics Agency pharmaceutical procurement projects. The requirement specifies USP 25mg per 5ml dry powder for oral suspension, ensuring all products adhere to USP standards. Delivery consists of seven bottles of medication shipped FOB Destination to Davis Monthan Air Force Base. The contract mandates strict compliance with MIL-STD-2073-1E and IP025 standards for the packaging and shipping of hazardous materials. Managed under the Department of Defense through the Medical Supply Chain Pharm FSA, the project falls under NAICS code 424210. The response deadline for this opportunity is September 28, 2026.

General Info

Supply Doxycycline Monohydrate oral suspension to Davis Monthan AFB by September 28, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

DAVIS MONTHAN AFB, AZ, 85707-6097, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-5183.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DOXYCYCLINE MONOHYDRAT

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Doxycycline Monohydrate for Oral Suspension for prime contractors on Defense Logistics Agency (DLA) pharmaceutical procurement projects. Provides USP 25mg per 5ml dry powder for oral suspension in accordance with USP standards. Adheres to MIL-STD-2073-1E and IP025 hazardous materials packaging and shipping requirements. Delivers 7 bottles of medication FOB Destination.

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-5154
Solicitation SPE2DP-26-T-5154 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of sunscreen preparation, identified by NSN 6505-01-657-9247. The requirement is for 10,000 packages, with each package containing 24 three-ounce tubes. The specified product must be an over-the-counter topical preparation containing 4.5 percent titanium dioxide and 4 percent zinc oxide, featuring an SPF of 50, 80-minute sweat and water resistance, and being hypoallergenic, oil-free, PABA-free, and biodegradable. The item has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements are specified between 15 and 30 degrees Celsius in a cool, dry place. Delivery is required within 20 days of award, with an original required delivery date of September 21, 2026, shipped FOB Destination to Oklahoma City, Oklahoma. Inspection and acceptance will occur at the destination. Packaging must adhere to the DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Non-hazardous materials must follow ASTM D3951, while hazardous materials must comply with TQ requirement IP025 and FED-STD-313. All items must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking, though general packaging must still align with MIL-STD-129 and palletization must follow RP001. The solicitation incorporates various FAR and DFARS clauses, including the Buy American Act, the Berry Amendment, and regulations regarding the safeguarding of covered defense information. Quotes must be submitted via DIBBS by September 23, 2026. Evaluation may include a HUBZone price preference, and offers utilizing additive manufacturing are ineligible for award. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS